{"id":"https://openalex.org/W7225777705","doi":"https://doi.org/10.3389/fphar.2026.1968909","title":"Atomoxetine-associated Raynaud\u2019s phenomenon in children: an under-recognized risk of non-stimulant ADHD therapy","display_name":"Atomoxetine-associated Raynaud\u2019s phenomenon in children: an under-recognized risk of non-stimulant ADHD therapy","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225777705","doi":"https://doi.org/10.3389/fphar.2026.1968909"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1968909","doi":"https://doi.org/10.3389/fphar.2026.1968909","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1968909","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.3389/fphar.2026.1968909","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022038376","display_name":"Wenxiu Mo","orcid":"https://orcid.org/0000-0001-5838-2185","observed_orcids":["https://orcid.org/0000-0001-5838-2185"]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210144404","display_name":"Beijing Children\u2019s Hospital","ror":"https://ror.org/04skmn292","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210144404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wenxiu Mo","raw_affiliation_strings":["Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210144404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161421041","display_name":"Lin Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210144404","display_name":"Beijing Children\u2019s Hospital","ror":"https://ror.org/04skmn292","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210144404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lin Liu","raw_affiliation_strings":["Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210144404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161444478","display_name":"Zheyu Cui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210144404","display_name":"Beijing Children\u2019s Hospital","ror":"https://ror.org/04skmn292","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210144404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zheyu Cui","raw_affiliation_strings":["Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210144404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161423106","display_name":"Yan Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210144404","display_name":"Beijing Children\u2019s Hospital","ror":"https://ror.org/04skmn292","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210144404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Yan Li","raw_affiliation_strings":["Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210144404"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5121196618","display_name":"Huawei Mao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183519381","display_name":"Capital Medical University","ror":"https://ror.org/013xs5b60","country_code":"CN","type":"education","lineage":["https://openalex.org/I183519381"]},{"id":"https://openalex.org/I4210144404","display_name":"Beijing Children\u2019s Hospital","ror":"https://ror.org/04skmn292","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210144404"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Huawei Mao","raw_affiliation_strings":["Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Rheumatology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Key Laboratory of Precision Diagnosis and Treatment of Pediatric Immune Diseases, Beijing Children\u2019s Hospital, Capital Medical University, National Center for Children\u2019s Health","institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210144404"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5121196618"],"corresponding_institution_ids":["https://openalex.org/I183519381","https://openalex.org/I4210144404"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","score":0.9785000085830688,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.018699999898672104,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.7479000091552734},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6718999743461609},{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.4869999885559082},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42989999055862427},{"id":"https://openalex.org/C192769605","wikidata":"https://www.wikidata.org/wiki/Q1418914","display_name":"Vigilance (psychology)","level":2,"score":0.3880999982357025},{"id":"https://openalex.org/C176233148","wikidata":"https://www.wikidata.org/wiki/Q14874257","display_name":"Norepinephrine transporter","level":4,"score":0.3806000053882599},{"id":"https://openalex.org/C190729725","wikidata":"https://www.wikidata.org/wiki/Q5012817","display_name":"CLs upper limits","level":2,"score":0.37860000133514404},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.37389999628067017},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.36419999599456787},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3467999994754791},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3440999984741211},{"id":"https://openalex.org/C3020000205","wikidata":"https://www.wikidata.org/wiki/Q2412849","display_name":"Narrative review","level":2,"score":0.3321000039577484},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.33000001311302185},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.32330000400543213},{"id":"https://openalex.org/C50335755","wikidata":"https://www.wikidata.org/wiki/Q483247","display_name":"Phenomenon","level":2,"score":0.321399986743927},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3208000063896179},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.319599986076355},{"id":"https://openalex.org/C2775894120","wikidata":"https://www.wikidata.org/wiki/Q271663","display_name":"Catecholamine","level":2,"score":0.31630000472068787},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2921999990940094},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.29159998893737793},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.28859999775886536},{"id":"https://openalex.org/C2777260799","wikidata":"https://www.wikidata.org/wiki/Q15637420","display_name":"Lethargy","level":2,"score":0.2858000099658966},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2847999930381775},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.2824999988079071},{"id":"https://openalex.org/C2778514916","wikidata":"https://www.wikidata.org/wiki/Q186242","display_name":"Norepinephrine","level":3,"score":0.2639000117778778},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.25920000672340393},{"id":"https://openalex.org/C2910584757","wikidata":"https://www.wikidata.org/wiki/Q334477","display_name":"Serotonin Uptake Inhibitors","level":5,"score":0.2574000060558319},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.25529998540878296},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.25130000710487366}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fphar.2026.1968909","doi":"https://doi.org/10.3389/fphar.2026.1968909","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1968909","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1968909","doi":"https://doi.org/10.3389/fphar.2026.1968909","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1968909","pdf_url":null,"source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":38,"referenced_works":["https://openalex.org/W85852026","https://openalex.org/W1885238897","https://openalex.org/W1975617196","https://openalex.org/W1977987856","https://openalex.org/W1980168095","https://openalex.org/W2000595776","https://openalex.org/W2005553418","https://openalex.org/W2009143564","https://openalex.org/W2032368646","https://openalex.org/W2034008127","https://openalex.org/W2038569697","https://openalex.org/W2062792880","https://openalex.org/W2067978628","https://openalex.org/W2076673968","https://openalex.org/W2081464955","https://openalex.org/W2089753359","https://openalex.org/W2110876400","https://openalex.org/W2123980944","https://openalex.org/W2141784450","https://openalex.org/W2163760904","https://openalex.org/W2166279367","https://openalex.org/W2475141720","https://openalex.org/W2544348120","https://openalex.org/W2573743698","https://openalex.org/W2614669943","https://openalex.org/W2615865527","https://openalex.org/W2887214886","https://openalex.org/W2954413740","https://openalex.org/W2968122415","https://openalex.org/W2988541321","https://openalex.org/W3099476886","https://openalex.org/W3201535527","https://openalex.org/W4210953367","https://openalex.org/W4401306218","https://openalex.org/W4406892073","https://openalex.org/W4413872386","https://openalex.org/W4416385566","https://openalex.org/W7204462746"],"related_works":[],"abstract_inverted_index":{"Raynaud\u2019s":[0],"phenomenon":[1],"(RP)":[2],"is":[3,18,115,127],"an":[4],"increasingly":[5],"recognized":[6],"yet":[7],"still":[8],"underreported":[9],"adverse":[10],"effect":[11],"of":[12,36,70,86,162,176],"ADHD":[13],"pharmacotherapy.":[14],"Whereas":[15],"stimulant-associated":[16],"RP":[17,22],"well":[19],"documented,":[20],"atomoxetine-related":[21],"has":[23],"surfaced":[24],"only":[25],"in":[26,33,49,104,124,154],"isolated":[27],"pediatric":[28,46,62],"cases,":[29,63],"leaving":[30],"a":[31,77],"gap":[32],"our":[34],"understanding":[35],"non-stimulant":[37],"toxicity.":[38],"This":[39],"narrative":[40],"review":[41],"reports":[42],"the":[43,56,84,90,122,142,157,171],"first":[44],"Asian":[45,106],"case":[47],"identified":[48],"English-":[50],"and":[51,54,67,72,121,129,179],"regional-language":[52],"literature":[53,65],"synthesizes":[55],"global":[57],"evidence":[58],"base,":[59],"integrating":[60],"five":[61,91],"targeted":[64],"retrieval,":[66],"disproportionality":[68],"analyses":[69],"FAERS":[71],"WHO":[73],"VigiBase.":[74],"Atomoxetine":[75],"carries":[76],"consistent":[78,136],"pharmacovigilance":[79,181],"signal":[80],"for":[81,167],"RP.":[82],"Beyond":[83],"elevation":[85,147],"synaptic":[87],"cleft":[88],"norepinephrine,":[89],"cases":[92,126],"point":[93],"to":[94,119,156],"suspected":[95],"contributors:":[96],"plasma":[97],"drug":[98],"concentration,":[99],"CYP2D6-mediated":[100],"metabolic":[101],"variability\u2014particularly":[102],"relevant":[103],"East":[105],"populations\u2014and":[107],"individual":[108],"susceptibility":[109],"with":[110],"superimposed":[111],"triggers.":[112],"Onset":[113],"latency":[114],"highly":[116],"variable":[117],"(hours":[118],"years),":[120],"course":[123],"reported":[125],"milder":[128],"fully":[130],"reversible,":[131],"without":[132],"digital":[133],"ulceration,":[134],"features":[135],"with,":[137],"though":[138],"not":[139],"determined":[140],"by,":[141],"sustained,":[143],"gradual":[144],"peripheral":[145],"noradrenergic":[146],"produced":[148],"by":[149],"selective":[150],"norepinephrine":[151],"transporter":[152],"inhibition,":[153],"contrast":[155],"rapid":[158],"catecholamine":[159],"surges":[160],"typical":[161],"stimulants.":[163],"These":[164],"findings":[165],"call":[166],"longitudinal":[168],"vigilance":[169],"beyond":[170],"titration":[172],"phase,":[173],"prompt":[174],"exclusion":[175],"secondary":[177],"causes,":[178],"systematic":[180],"reporting.":[182]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}